AXSMNasdaq United States
Market cap
$10.948 B
$212.74 +1.24%
Close of 7 Aug 2026
Revenue
$638.5M
#1791 by revenue
Earnings
-$183.2M
Loss-making
Shares outstanding
51,459,766
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Axsome Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.